What is the outcome of drug-eluting stents versus bare-metal stents in patients with acute myocardial infarction?
A meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction showed that drug-eluting stents resulted in a reduced risk of major adverse cardiac events, target vessel revascularization, and stent thrombosis at 1 year follow-up compared to bare-metal stents. (Kastrati et al., 2007)